When tirzepatide makes migraines worse Science is never as clean as we want it to be
Established Compliance Committees in European Direct Markets
Inflammatory Bowel Disease 17:2318-2325, 2011
METHODS: In this double-blind trial, we enrolled 1961 adults with a body-mass index (the weight in kilograms divided by the square of the height in meters) of 30 or greater (27 in persons with 1 weight-related coexisting condition), who did not have diabetes, and randomly assigned them, in a 2:1 ratio, to 68 weeks of treatment with once-weekly subcutaneous semaglutide (at a dose of 2.4 mg) or placebo, plus lifestyle intervention
Signs Your Compounded Semaglutide Has Degraded and Should Be Discarded Visual changes indicate degradation: discoloration, cloudiness, or visible particles in the solution warrant immediate discard
The trial ended after 70 weeks for patients who did not qualify as having pre-diabetes (i.e., their blood glucose levels were higher than normal but did not require medication)